Get the Stockscreener App
2.13
1.43%
0.03
Alaunos Therapeutics Inc stock is traded at $2.13, with a volume of 55,238.
It is up +1.43% in the last 24 hours and down -23.10% over the past month.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.10
Open:
$2.075
24h Volume:
55,238
Relative Volume:
0.40
Market Cap:
$4.70M
Revenue:
-
Net Income/Loss:
$-36.46M
P/E Ratio:
-0.8875
EPS:
-2.4
Net Cash Flow:
$-30.20M
1W Performance:
+20.34%
1M Performance:
-23.10%
6M Performance:
+33.12%
1Y Performance:
-20.22%
1-Day Range:
$2.06
$2.31
1-Week Range:
$1.83
$2.31
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
2617 BISSONNET ST, HOUSTON
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.13 | 4.15M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
Momentum divergence signals in Alaunos Therapeutics Inc. chartMarket Risk Analysis & Growth Oriented Trade Recommendations - Newser
What’s the recovery path for long term holders of Alaunos Therapeutics Inc.Market Activity Report & Smart Swing Trading Techniques - Newser
Intraday pattern recognizer results for Alaunos Therapeutics Inc.New Guidance & Free Accurate Trade Setup Notifications - Newser
Will Alaunos Therapeutics Inc. outperform the market2025 Top Decliners & Daily Profit Focused Screening - Newser
What MACD signals say about Alaunos Therapeutics Inc.July 2025 Trends & Growth Oriented Trade Recommendations - Newser
Will Alaunos Therapeutics Inc. stock go up soonPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Full technical analysis of Alaunos Therapeutics Inc. stock2025 Biggest Moves & Safe Swing Trade Setups - Newser
Volatility clustering patterns for Alaunos Therapeutics Inc.Layoff News & Safe Entry Point Alerts - Newser
Real time social sentiment graph for Alaunos Therapeutics Inc.Quarterly Profit Summary & Consistent Growth Stock Picks - Newser
Is Alaunos Therapeutics Inc. stock entering bullish territory2025 Historical Comparison & Risk Managed Trade Strategies - Newser
Screener Results Flag Alaunos Therapeutics Inc. as OversoldPortfolio Gains Report & Breakout Confirmation Alerts - beatles.ru
Key resistance and support levels for Alaunos Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - Newser
Using data filters to optimize entry into Alaunos Therapeutics Inc.2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - Newser
Custom watchlist performance reports with Alaunos Therapeutics Inc.2025 Retail Activity & Verified Entry Point Signals - Newser
Reversal indicators forming on Alaunos Therapeutics Inc. stockJuly 2025 Retail & Risk Managed Investment Signals - Newser
Why Alaunos Therapeutics Inc. stock attracts strong analyst attention2025 Top Gainers & Technical Pattern Alert System - Newser
Analyzing drawdowns of Alaunos Therapeutics Inc. with statistical toolsJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
How to monitor Alaunos Therapeutics Inc. with trend dashboardsWeekly Trade Recap & Fast Entry High Yield Tips - Newser
Is Alaunos Therapeutics Inc. forming a reversal patternBuy Signal & Risk Controlled Stock Alerts - Newser
Combining machine learning predictions for Alaunos Therapeutics Inc.Quarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Candlestick signals on Alaunos Therapeutics Inc. stock todayOil Prices & Capital Efficient Trading Techniques - Newser
What’s next for Alaunos Therapeutics Inc. stock priceInsider Selling & Weekly High Return Stock Opportunities - Newser
What recovery options are there for Alaunos Therapeutics Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - Newser
How sentiment analysis helps forecast Alaunos Therapeutics Inc.July 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications - MSN
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):